Journey Medical (DERM) Change in Account Payables (2020 - 2026)
Journey Medical (DERM) posted Change in Account Payables of -$649000.0 for Q1 2026, up 76.02% on a QoQ basis from -$2.7 million in Q4 2025, and up 60.57% year-over-year from -$404182.4 in Q1 2025.
Journey Medical (DERM) Change in Account Payables (2020 - 2026) Analysis & Trends
Journey Medical's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$649000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 60.57% year-over-year to -$649000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.2 million (down 560.49% YoY) and the FY2025 annual result came in at -$7.2 million, down 242.97% from the prior year.
- Change in Account Payables was -$649000.0 for Q1 2026 at Journey Medical, up from -$2.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.1 million in Q1 2023 and bottomed at -$11.9 million in Q2 2023.
- A 5-year average of -$825000.0 and a median of -$739000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 736.04% — and 2023, when it tumbled 511.99%.
- Journey Medical's Change in Account Payables stood at $2.9 million in 2022, then sank by 440.18% to -$10.0 million in 2023, then soared by 107.1% to $711000.0 in 2024, then tumbled by 480.59% to -$2.7 million in 2025, then surged by 76.02% to -$649000.0 in 2026.
- Business Quant data shows DERM's Change in Account Payables at -$649000.0 in Q1 2026, -$2.7 million in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -649,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -649,000.00 |
| Mar 31, 2026 | -649,000.00 |
| Dec 31, 2025 | -2.71 Mn |
| Dec 31, 2025 | -2.71 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.65 Mn |
| Dec 31, 2024 | 711,000.00 |
| Dec 31, 2024 | 711,000.00 |
| Sep 30, 2024 | 735,000.00 |
| Sep 30, 2024 | 735,000.00 |
| Jun 30, 2024 | -739,000.00 |
| Jun 30, 2024 | -739,000.00 |
| Mar 31, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.81 Mn |
| Dec 31, 2023 | -10.02 Mn |
| Dec 31, 2023 | -10.02 Mn |